Publicacions en què col·labora amb MANUEL SÁNCHEZ SANTOS (44)

2024

  1. Differing contributions of the gut microbiota to the blood pressure lowering effects induced by first-line antihypertensive drugs

    British Journal of Pharmacology

2023

  1. Mineralocorticoid receptor blockade improved gut microbiota dysbiosis by reducing gut sympathetic tone in spontaneously hypertensive rats

    Biomedicine and Pharmacotherapy, Vol. 158

  2. Protective effect of microbiota-derived short chain fatty acids on vascular dysfunction in mice with systemic lupus erythematosus induced by toll like receptor 7 activation

    Pharmacological Research, Vol. 198

2022

  1. The melatonergic agonist agomelatine ameliorates high fat diet-induced obesity in mice through the modulation of the gut microbiome

    Biomedicine and Pharmacotherapy, Vol. 153

2021

  1. Allium-derived compound propyl propane thiosulfonate (Ptso) attenuates metabolic alterations in mice fed a high-fat diet through its anti-inflammatory and prebiotic properties

    Nutrients, Vol. 13, Núm. 8

  2. Changes in gut microbiota induced by doxycycline influence in vascular function and development of hypertension in doca-salt rats

    Nutrients, Vol. 13, Núm. 9

  3. Gut microbiota contributes to the development of hypertension in a genetic mouse model of systemic lupus erythematosus

    British Journal of Pharmacology, Vol. 178, Núm. 18, pp. 3708-3729

  4. Gut microbiota has a crucial role in the development of hypertension and vascular dysfunction in toll-like receptor 7-driven lupus autoimmunity

    Antioxidants, Vol. 10, Núm. 9

  5. Mycophenolate mediated remodeling of gut microbiota and improvement of gut-brain axis in spontaneously hypertensive rats

    Biomedicine and Pharmacotherapy, Vol. 135

  6. Probiotics prevent hypertension in a murine model of systemic lupus erythematosus induced by toll-like receptor 7 activation

    Nutrients, Vol. 13, Núm. 8

2020

  1. Changes to the gut microbiota induced by losartan contributes to its antihypertensive effects

    British Journal of Pharmacology, Vol. 177, Núm. 9, pp. 2006-2023

  2. Lactobacillus fermentum CECT5716 prevents renal damage in the NZBWF1 mouse model of systemic lupus erythematosus

    Food & function, Vol. 11, Núm. 6, pp. 5266-5274

  3. Mycophenolate improves brain–gut axis inducing remodeling of gut microbiota in doca-salt hypertensive rats

    Antioxidants, Vol. 9, Núm. 12, pp. 1-18

  4. Probiotic Bifidobacterium breve prevents DOCA-salt hypertension

    FASEB Journal, Vol. 34, Núm. 10, pp. 13626-13640

  5. Probiotics Prevent Dysbiosis and the Rise in Blood Pressure in Genetic Hypertension: Role of Short-Chain Fatty Acids

    Molecular Nutrition and Food Research, Vol. 64, Núm. 6

  6. Toll-like receptor 7-driven lupus autoimmunity induces hypertension and vascular alterations in mice

    Journal of hypertension, Vol. 38, Núm. 7, pp. 1322-1335

2019

  1. Cardiovascular effects of flavonoids

    Current Medicinal Chemistry, Vol. 26, Núm. 39, pp. 6991-7034

  2. Critical role of the interaction gut microbiota-sympathetic nervous system in the regulation of blood pressure

    Frontiers in Physiology, Vol. 10, Núm. MAR

  3. Lactobacillus fermentum CECT5716: a novel alternative for the prevention of vascular disorders in a mouse model of systemic lupus erythematosus

    FASEB Journal, Vol. 33, Núm. 9, pp. 10005-10018

  4. Role of the immune system in vascular function and blood pressure control induced by faecal microbiota transplantation in rats

    Acta Physiologica, Vol. 227, Núm. 1